Iattoni, Elena
 Distribuzione geografica
Continente #
NA - Nord America 649
EU - Europa 311
AS - Asia 119
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.081
Nazione #
US - Stati Uniti d'America 635
GB - Regno Unito 113
SE - Svezia 55
IE - Irlanda 46
CN - Cina 42
IT - Italia 29
SG - Singapore 27
DE - Germania 24
HK - Hong Kong 24
UA - Ucraina 17
CA - Canada 13
FR - Francia 9
ID - Indonesia 8
FI - Finlandia 7
BG - Bulgaria 6
TR - Turchia 6
VN - Vietnam 6
IN - India 3
NL - Olanda 3
EU - Europa 2
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
Totale 1.081
Città #
Fairfield 95
Southend 89
Santa Clara 69
Ashburn 55
Chandler 54
Woodbridge 47
Dublin 46
Wilmington 40
Nyköping 37
Dearborn 36
Seattle 36
Houston 32
Jacksonville 29
Cambridge 24
Hong Kong 24
Singapore 23
Ann Arbor 14
Beijing 12
Ottawa 12
Modena 9
Jakarta 8
San Diego 8
Eugene 7
Helsinki 6
Princeton 6
Sofia 6
Falls Church 5
London 5
New York 5
Dong Ket 4
Izmir 4
San Mateo 4
Bremen 3
Guangzhou 3
Redwood City 3
Shanghai 3
Bra 2
Hanoi 2
Jinan 2
Kunming 2
Nanjing 2
San Giuliano Milanese 2
Shenyang 2
Turin 2
Boardman 1
Brno 1
Chiswick 1
Chongqing 1
Dongguan 1
Fremont 1
Fuzhou 1
Groningen 1
Jining 1
Los Angeles 1
Milan 1
Monmouth Junction 1
Mountain View 1
Munich 1
Nanchang 1
Napoli 1
Nürnberg 1
Phoenix 1
Pune 1
Rome 1
Segrate 1
Targu 1
Tehran 1
Tokyo 1
Toronto 1
Xi'an 1
Zhengzhou 1
Totale 906
Nome #
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 220
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer. 204
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 181
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 174
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 173
Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer. 138
Totale 1.090
Categoria #
all - tutte 3.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 0 29 37 25 15 10 12 4
2020/2021203 19 2 9 7 6 29 9 37 12 21 17 35
2021/2022154 11 34 2 4 9 17 7 12 13 10 23 12
2022/2023182 26 23 8 13 22 13 6 4 58 1 3 5
2023/202475 2 4 4 12 14 7 14 6 0 1 0 11
2024/2025115 12 0 11 10 54 28 0 0 0 0 0 0
Totale 1.090